Direct-Acting Antiviral Drugs and Occurrence of Hepatocellular Carcinoma: Unjust or Oppressed.

Hassany, Sahar M; Hassan, Wesam; Abo-Alam, Hany; Khalaf, Marwa; Nafeh, Amany M; Nasr-Eldin, Eman; Mostafa, Ehab F

Hassany, Sahar M; Hassan, Wesam; Abo-Alam, Hany; Khalaf, Marwa; Nafeh, Amany M; Nasr-Eldin, Eman; Mostafa, Ehab F.

Afiliação

Hassany SM; Tropical Medicine and Gastroenterology Department, Alrajhi University Hospital, Assiut University, Assiut, Egypt.
Hassan W; Hepatology Centre, Ministry of Heath, Assiut, Egypt.
Abo-Alam H; Hepatology Centre, Ministry of Heath, Assiut, Egypt.
Khalaf M; Hepatology Centre, Ministry of Heath, Assiut, Egypt.
Nafeh AM; Microbiology and Immunity Department, Assiut University, Assiut, Egypt.
Nasr-Eldin E; Clinical Pathology Department, Assiut University, Assiut, Egypt.
Mostafa EF; Tropical Medicine and Gastroenterology Department, Alrajhi University Hospital, Assiut University, Assiut, Egypt.

Infect Drug Resist ; 13: 1873-1880, 2020.

Article em En | MEDLINE | ID: mdl-32606836

Palavras-chave

HCV treatment; de-novo HCC occurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Infect Drug Resist Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google